LEO Pharma receives positive CHMP opinion of Adtralza by John Pinching | Sep 20, 2022 | News | 0 Therapy is for the treatment of adolescents with moderate-to-severe atopic dermatitis Read More
NICE recommend’s use of Leo Pharma’s Adtralza by John Pinching | Jul 7, 2022 | News | 0 The therapy is for moderate-to-severe atopic dermatitis in adult patients who are candidates for systemic treatment Read More
Roche’s Enspryng leads latest CHMP recommendations by Lucy Parsons | Apr 26, 2021 | News | 0 CHMP adopted positive opinions for eight new medicines in its April meeting Read More